1. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol. 1953 Dec;26(312):638–48. Available from: https://www.birpublications.org/doi/epdf/10.1259/0007-1285-26-312-638
2. Barendsen GW. Responses of cultured cells, tumours and normal tissues to radiations of different linear energy transfer. pp 293-356 Curr Top Radiat Res Vol IV Ebert, Michael Howard, Alma (eds) New York, John Wiley Sons, Inc, 1968 [Internet]. Available from: https://www.osti.gov/biblio/4500126
3. Prise KM, Folkard M, Davies S, Michael BD. The Irradiation of V79 Mammalian Cells by Protons with Energies below 2 MeV. Part II. Measurement of Oxygen Enhancement Ratios and DNA Damage. Int J Radiat Biol [Internet]. 1990 Jan 1;58(2):261–77. Available from: https://doi.org/10.1080/09553009014551611
4. Nakano T, Suzuki Y, Ohno T, Kato S, Suzuki M, Morita S, et al. Carbon beam therapy overcomes the radiation resistance of uterine cervical cancer originating from hypoxia. Clin Cancer Res. 2006;12:2185–90.Available from: https://clincancerres.aacrjournals.org/content/clincanres/12/7/2185.full.pdf
5. Bassler N, Jäkel O, Søndergaard CS, Petersen JB. Dose- and LET-painting with particle therapy. Acta Oncol. 2010;49(July):1170–6. Available from: https://www.tandfonline.com/doi/pdf/10.3109/0284186X.2010.510640?needAccess=true
6. Hirayama R, Furusawa Y, Fukawa T, Ando K. Repair kinetics of DNA-DSB induced by X-rays or carbon ions under oxic and hypoxic conditions. J Radiat Res. 2005;46(3):325–32. Available rom: https://doi.org/10.1269/jrr.46.325
7. Mohan R, Grosshans D. Proton therapy – Present and future. Adv Drug Deliv Rev [Internet]. 2017;109:26–44. Available from: http://dx.doi.org/10.1016/j.addr.2016.11.006
8. Fowler JF. What can we expect from dose escalation using proton beams? Clin Oncol. 2003;15(1):10–5. Available from: https://reader.elsevier.com/reader/sd/pii/S0936655502901822?token=DEC9BA131603F312B5FF17AEF4B42FF8D66E872C3B08FFD2064192520F887FA48723821AC97D9D5480CA905D911071ED&originRegion=eu-west-1&originCreation=20210629140944
9. Montay-Gruel P, Acharya MM, Petersson K, Alikhani L, Yakkala C, Allen BD, et al. Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species. Proc Natl Acad Sci U S A. 2019;166(22):10943–51. Available from: https://doi.org/10.1073/pnas.1901777116
10. Montay-Gruel P, Meziani L, Yakkala C, Vozenin MC. Expanding the therapeutic index of radiation therapy by normal tissue protection. Br J Radiol. 2019;92(1093). Available from: https://doi.org/10.1259/bjr.20180008
11. Diffenderfer ES, Verginadis II, Kim MM, Shoniyozov K, Velalopoulou A, Goia D, et al. Design, Implementation, and in Vivo Validation of a Novel Proton FLASH Radiation Therapy System. Int J Radiat Oncol Biol Phys [Internet]. 2020;106(2):440–8. Available from: https://doi.org/10.1016/j.ijrobp.2019.10.049
12. Doria D, Kakolee KF, Kar S, Litt SK, Fiorini F, Ahmed H, et al. Biological effectiveness on live cells of laser driven protons at dose rates exceeding 109 Gy/s. AIP Adv. 2012;2(1). Available from: https://doi.org/10.1063/1.3699063
13. Yogo A, Maeda T, Hori T, Sakaki H, Ogura K, Nishiuchi M, et al. Measurement of relative biological effectiveness of protons in human cancer cells using a laser-driven quasimonoenergetic proton beamline. Appl Phys Lett [Internet]. 2011 Jan 31;98(5):053701. Available from: http://aip.scitation.org/doi/10.1063/1.3551623
14. Zeil K, Baumann M, Beyreuther E, Burris-Mog T, Cowan TE, Enghardt W, et al. Dose-controlled irradiation of cancer cells with laser-accelerated proton pulses. Appl Phys B Lasers Opt. 2013;110(4):437–44.
15. Bin J, Allinger K, Assmann W, Dollinger G, Drexler GA, Friedl AA, et al. A laser-driven nanosecond proton source for radiobiological studies. Appl Phys Lett. 2012;101(24). Available from: https://doi.org/ 10.1007/s00340-012-5275-3
16. Cygler J, Klassen N, Ross C, Bichay T, Raaphorst G. The survival of aerobic and anoxic human glioma and melanoma cells after irradiation at ultrahigh and clinical dose rates. Radiat Res [Internet]. 1994;140(1):79–84. Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&%2338;dopt=Citation&%2338;list_uids=7938458
17. Hanton F, Chaudhary P, Doria D, Gwynne D, Maiorino C, Scullion C, et al. DNA DSB Repair Dynamics following Irradiation with Laser- Driven Protons at Ultra-High Dose Rates. Sci Rep [Internet]. 2019;(February):1–10. Available from: http://dx.doi.org/10.1038/s41598-019-40339-6
18. Manti L, Perozziello FM, Borghesi M, Candiano G, Chaudhary P, Cirrone GAP, et al. The radiobiology of laser-driven particle beams: focus on sub-lethal responses of normal human cells. J Instrum [Internet]. 2017;12(03):C03084. Available from: http://stacks.iop.org/1748-0221/12/i=03/a=C03084
19. Weiss H, Epp ER, Heslin JM, Ling CC, Santomasso A. Oxygen Depletion in Cells Irradiated at Ultra-high Dose-rates and at Conventional Dose-rates. Int J Radiat Biol Relat Stud Physics, Chem Med [Internet]. 1974 Jan 1;26(1):17–29. Available from: https://doi.org/10.1080/09553007414550901
20. Durante M, Brauer-Krisch E, Hill M. Faster and safer? FLASH ultra-high dose rate in radiotherapy. Br J Radiol [Internet]. 2017;(November 2017):20170628. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29172684%0Ahttp://www.birpublications.org/doi/10.1259/bjr.20170628
21. Favaudon V, Caplier L, Monceau V, Pouzoulet F, Sayarath M, Fouillade C, et al. Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice. Sci Transl Med. 2014;6(245):1–10.Available from:https://doi.org/10.1126/scitranslmed.3008973
22. Montay-Gruel P, Petersson K, Jaccard M, Boivin G, Germond JF, Petit B, et al. Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100Gy/s. Radiother Oncol [Internet]. 2016;124(3):365–9. Available from: http://dx.doi.org/10.1016/j.radonc.2017.05.003
23. Adrian G, Konradsson E, Lempart M, Bäck S, Ceberg C, Petersson K. The FLASH effect depends on oxygen concentration. Br J Radiol. 2020;93(1106). Available from: https://doi.org/10.1259/bjr.20190702
24. Petersson K, Adrian G, Butterworth K, McMahon SJ. A Quantitative Analysis of the Role of Oxygen Tension in FLASH Radiation Therapy. Int J Radiat Oncol Biol Phys [Internet]. 2020;107(3):539–47. Available from: https://doi.org/10.1016/j.ijrobp.2020.02.634
25. Khan S, Bassenne M, Wang J, Manjappa R, Melemenidis S, Breitkreutz DY, et al. Multicellular spheroids as in vitro models of oxygen depletion during FLASH irradiation. Int J Radiat Oncol [Internet]. 2021;1–12. Available from: https://doi.org/10.1016/j.ijrobp.2021.01.050
26. Lee, Kheun Byeol,Kim Kye-Ryung H tae-L and LMY. Proton induces apoptosis of hypoxic tumor cells by the p53-dependent and p38/JNK MAPK signalling pathways. Int J Oncol [Internet]. 2008;33:1247–56. Available from: https://doi.org/10.3892/ijo_00000115
27. Ma NY, Tinganelli W, Maier A, Durante M, Kraft-Weyrather W. Influence of chronic hypoxia and radiation quality on cell survival. J Radiat Res. 2013;54:13–22. Available from: https://doi.org/10.1093/jrr/rrs135
28. Tinganelli W, Durante M, Hirayama R, Krämer M, Maier A, Kraft-Weyrather W, et al. Kill-painting of hypoxic tumours in charged particle therapy. Sci Rep. 2015;5:1–13. Available from: https://doi.org/ 10.1038/srep17016
29. Kanemoto a., Hirayama R, Moritake T, Furusawa Y, Sun L, Sakae T, et al. RBE and OER within the spread-out Bragg peak for proton beam therapy: in vitro study at the Proton Medical Research Center at the University of Tsukuba. J Radiat Res [Internet]. 2014;55(5):1028–32. Available from: http://jrr.oxfordjournals.org/cgi/doi/10.1093/jrr/rru043
30. Kumareswaran R, Ludkovski O, Meng a., Sykes J, Pintilie M, Bristow RG. Chronic hypoxia compromises repair of DNA double-strand breaks to drive genetic instability. J Cell Sci. 2012;125:189–99. Available from: https://doi.org/ 10.1242/jcs.092262
31. Vordermark D, Menke DR, Brown JM, Ma N-YN-Y, Tinganelli W, Maier A, et al. Similar Radiation Sensitivities of Acutely and Chronically Hypoxic Cells in HT 1080 Fibrosarcoma Xenografts. Nat Rev Cancer [Internet]. 2013 Jul 1 [cited 2014 Jul 21];4(1):443–7. Available from: http://dx.doi.org/10.1016/j.jscs.2010.02.005
32. Metsälä O, Kreutzer J, Högel H, Miikkulainen P, Kallio P, Jaakkola PM. Transportable system enabling multiple irradiation studies under simultaneous hypoxia in vitro. Radiat Oncol. 2018;13(1):220. Available from: 3:220 https://doi.org/10.1186/s13014-018-1169-9
33. Tinganelli W, Ma NY, Von Neubeck C, Maier A, Schicker C, Kraft-Weyrather W, et al. Influence of acute hypoxia and radiation quality on cell survival. J Radiat Res. 2013;54(SUPPL.1):23–30. Available from:https://doi.org/ 10.1093/jrr/rrt065
34. Snavely R a, Key MH, Hatchett SP, Cowan TE, Roth M, Phillips TW, et al. Intense high-energy proton beams from Petawatt-laser irradiation of solids. Phys Rev Lett [Internet]. 2000 Oct 2;85(14):2945–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11005974
35. Macchi A, Borghesi M, Passoni M. Ion acceleration by superintense laser-plasma interaction. Rev Mod Phys [Internet]. 2013 May [cited 2013 Aug 19];85(2):751–93. Available from: http://link.aps.org/doi/10.1103/RevModPhys.85.751
36. Chaudhary P, Marshall TI, Perozziello FM, Manti L, Currell FJ, Hanton F, et al. Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: A preclinical assessment. Int J Radiat Oncol Biol Phys. 2014;90(1). Available from:https://doi.org/ 10.1016/j.ijrobp.2014.05.010
37. McKeown SR. Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response. Br J Radiol. 2014;87(October 2013):20130676. Available from: https://www.birpublications.org/doi/10.1259/bjr.20130676
38. Neumaier T, Swenson J, Pham C, Polyzos a., Lo a. T, Yang P, et al. From the Cover: Evidence for formation of DNA repair centers and dose-response nonlinearity in human cells. Proc Natl Acad Sci. 2012;109(2):443–8. Available from: https://www.pnas.org/content/109/2/443
39. Asaithamby A, Chen DJ. Cellular responses to DNA double-strand breaks after low-dose gamma-irradiation. Nucleic Acids Res [Internet]. 2009 Jul [cited 2012 Oct 26];37(12):3912–23. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2709554&tool=pmcentrez&rendertype=abstract
40. Panier S, Boulton SJ. Double-strand break repair: 53BP1 comes into focus. Nat Rev Mol Cell Biol [Internet]. 2014 Jan [cited 2014 Jul 10];15(1):7–18. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24326623
41. Zimmermann M, de Lange T. 53BP1: pro choice in DNA repair. Trends Cell Biol [Internet]. 2014 Feb [cited 2014 Jul 14];24(2):108–17. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24094932
42. Hanton F, Chaudhary P, Doria D, Gwynne D, Maiorino C, Scullion C, et al. DNA DSB Repair Dynamics following Irradiation with Laser-Driven Protons at Ultra-High Dose Rates. Sci Rep. 2019;9(1). Available from: https://www.nature.com/articles/s41598-019-40339-6.pdf
43. Freyer JP, Jarrett K, Carpenter S, Raju MR. Oxygen enhancement ratio as a function of dose and cell cycle phase for radiation-resistant and sensitive CHO cells. Radiat Res. 1991;127(3):297–307. Available from: https://pubmed.ncbi.nlm.nih.gov/1886986/
44. Wenzl T, Wilkens JJ. Theoretical analysis of the dose dependence of the oxygen enhancement ratio and its relevance for clinical applications. Radiat Oncol. 2011;6(1):1–9. Available from: https://ro-journal.biomedcentral.com/track/pdf/10.1186/1748-717X-6-171.pdf
45. Burroughs SK, Kaluz S, Wang D, Wang K, Meir EG Van, Wang B. Hypoxia inducible factor pathway inhibitors as anticancer therapeutics. Future Med Chem 2014;5(5):1–31. Available from: https://doi.org/10.4155/fmc.13.17
46. Busk M, Overgaard J, Horsman MR. Imaging of Tumor Hypoxia for Radiotherapy: Current Status and Future Directions. Semin Nucl Med. 2020;50(6):562–83. availbe from: https;//doi.org/ 10.1053/j.semnuclmed.2020.05.003
47. Malinen E, Søvik Å. Dose or LET painting - What is optimal in particle therapy of hypoxic tumors? Acta Oncol (Madr). 2015;54(9):1614–22. Available from: https://doi.org/10.3109/0284186X.2015.1062540
48. Chang JH, Wada M, Anderson NJ, Lim Joon D, Lee ST, Gong SJ, et al. Hypoxia-targeted radiotherapy dose painting for head and neck cancer using (18)F-FMISO PET: a biological modeling study. Acta Oncol [Internet]. 2013;52(December 2012):1723–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23317145
49. Marshall TI, Chaudhary P, Michaelidesová A, Vachelová J, Davídková M, Vondráček V, et al. Investigating the Implications of a Variable RBE on Proton Dose Fractionation Across a Clinical Pencil Beam Scanned Spread-Out Bragg Peak. Int J Radiat Oncol Biol Phys. 2016;95(1):70–7. Available from: https://doi.org/10.1016/j.ijrobp.2016.02.029
50. Yang H, Anzenberg V, Held KD. The time dependence of bystander responses induced by iron-ion radiation in normal human skin fibroblasts. Radiat Res. 2007;168(3):292–8. Available from:https://doi.org/ 10.1667/RR0864.1
51. Shao C, Prise KM, Folkard M. Signaling factors for irradiated glioma cells induced bystander responses in fibroblasts. Mutat Res - Fundam Mol Mech Mutagen. 2008;638(1–2):139–45. Available from: https://doi.org/10.1016/j.mrfmmm.2007.09.007
52. Nieri D, Berardinelli F, Sgura A, Cherubini R, De Nadal V, Gerardi S, et al. Cyogenetics effects in AG01522 human primary fibroblasts exposed to low doses of radiations with different quality. Int J Radiat Biol [Internet]. 2013 Sep [cited 2014 Jul 23];89(9):698–707. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23607438
53. Chaudhary P, Marshall TI, Currell FJ, Kacperek A, Schettino G, Prise KM. Variations in the Processing of DNA Double-Strand Breaks Along 60-MeV Therapeutic Proton Beams. Int J Radiat Oncol Biol Phys. 2016;95(1):86–94. Available from: https://doi.org/10.1016/j.ijrobp.2015.07.2279
54. Ahmed U, Carruthers R, Gilmour L, Yildirim S, Watts C, Chalmers AJ. Selective Inhibition of Parallel DNA Damage Response Pathways Optimizes Radiosensitization of Glioblastoma Stem-like Cells. 2015;75(21). Available from: https://doi.org/10.1158/0008-5472.CAN-14-3790
55. Carruthers R, Ahmed SU, Strathdee K, Gomez-roman N, Amoah-buahin E, Watts C, et al. ScienceDirect Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase. Mol Oncol [Internet]. 2014;9(1):192–203. Available from: http://dx.doi.org/10.1016/j.molonc.2014.08.003
56. Mannino M, Gomez-roman N, Hochegger H, Chalmers AJ. ScienceDirect Differential sensitivity of Glioma stem cells to Aurora kinase A inhibitors : Implications for stem cell mitosis and centrosome dynamics. Stem Cell Res [Internet]. 2014;13(1):135–43. Available from: http://dx.doi.org/10.1016/j.scr.2014.05.001
57. Gomez-Roman N, Stevenson K, Gilmour L, Hamilton G, Chalmers AJ. A novel 3D human glioblastoma cell culture system for modeling drug and radiation responses. Neuro Oncol. 2017;19(2):229–41. Available from: https://doi.org/10.1093/neuonc/now164
58. Raschke S, Spickermann S, Toncian T, Swantusch M, Boeker J, Giesen U, et al. Ultra-short laser-accelerated proton pulses have similar DNA-damaging effectiveness but produce less immediate nitroxidative stress than conventional proton beams. Sci Rep [Internet]. 2016;6(1):32441. Available from: http://www.nature.com/articles/srep32441
59. Montay-Gruel P, Petersson K, Jaccard M, Boivin G, Germond JF, Petit B, et al. Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100 Gy/s. Radiother Oncol [Internet]. 2017;124(3):365–9. Available from: http://dx.doi.org/10.1016/j.radonc.2017.05.003
60. Bourton EC, Plowman PN, Smith D, Arlett CF, Parris CN. Prolonged expression of the γ-H2AX DNA repair biomarker correlates with excess acute and chronic toxicity from radiotherapy treatment. Int J Cancer [Internet]. 2011 Dec 15 [cited 2014 Oct 2];129(12):2928–34. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3427882&tool=pmcentrez&rendertype=abstract
61. Najafi M, Farhood B, Mortezaee K, Kharazinejad E, Majidpoor J, Ahadi R. Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance. J Cancer Res Clin Oncol [Internet]. 2020;146(1):19–31. Available from: https://doi.org/10.1007/s00432-019-03080-1
62. Antonovic L, Lindblom E, Dasu A, Bassler N, Furusawa Y, Toma-Dasu I. Clinical oxygen enhancement ratio of tumors in carbon ion radiotherapy: the influence of local oxygenation changes. J Radiat Res [Internet]. 2014;(April):1–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24728013
63. Puck TT, Marcus PI. Action of X-rays on mammalian cells. J Exp Med
. 1956 May 1;103(5):653-66.Available from:https://doi.org/10.1084/jem.103.5.653
64. Butterworth KT, McGarry CK, Clasie B, Carabe-Fernandez A, Schuemann J, Depauw N, et al. Relative biological effectiveness (RBE) and out-of-field cell survival responses to passive scattering and pencil beam scanning proton beam deliveries. Phys Med Biol [Internet]. 2012 Oct 21 [cited 2013 Aug 5];57(20):6671–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23022765
65. Thompson HF, Butterworth KT, McMahon SJ, Ghita M, Hounsell AR, Prise KM. The Impact of Hypoxia on Out-of-Field Cell Survival after Exposure to Modulated Radiation Fields. Radiat Res. 2017;188(6):716–24. Available from:https://doi.org/ 10.1667/RR14836.1